PFG Investments LLC Sells 27,930 Shares of Omega Healthcare Investors, Inc. $OHI

PFG Investments LLC lessened its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 39.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,832 shares of the real estate investment trust's stock after selling 27,930 shares during the period. PFG Investments LLC's holdings in Omega Healthcare Investors were worth $1,570,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. NBC Securities Inc. acquired a new stake in shares of Omega Healthcare Investors during the first quarter worth $29,000. MassMutual Private Wealth & Trust FSB increased its position in shares of Omega Healthcare Investors by 562.3% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust's stock worth $67,000 after acquiring an additional 1,552 shares in the last quarter. Register Financial Advisors LLC purchased a new position in Omega Healthcare Investors during the second quarter worth about $73,000. UMB Bank n.a. boosted its holdings in Omega Healthcare Investors by 94.9% during the first quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock worth $83,000 after purchasing an additional 1,059 shares during the last quarter. Finally, Meeder Asset Management Inc. boosted its stake in Omega Healthcare Investors by 1,581.3% in the first quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust's stock valued at $96,000 after acquiring an additional 2,372 shares during the last quarter. Institutional investors own 65.25% of the company's stock.

Insiders Place Their Bets

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the transaction, the director owned 18,654 shares in the company, valued at approximately $749,144.64. This represents a 11.82% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.50% of the company's stock.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Truist Financial upped their price target on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research note on Wednesday, September 3rd. Raymond James Financial reaffirmed an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Royal Bank Of Canada increased their price target on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research report on Thursday, August 7th. Scotiabank raised their target price on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a research report on Thursday, August 28th. Finally, Cantor Fitzgerald initiated coverage on shares of Omega Healthcare Investors in a research report on Wednesday. They set an "overweight" rating and a $50.00 price target for the company. Six investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Omega Healthcare Investors has a consensus rating of "Moderate Buy" and an average price target of $44.44.

Omega Healthcare Investors Trading Up 0.2%

OHI stock opened at $42.30 on Thursday. The firm's fifty day simple moving average is $41.33 and its two-hundred day simple moving average is $38.66. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $12.48 billion, a price-to-earnings ratio of 26.11, a price-to-earnings-growth ratio of 2.21 and a beta of 0.70. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $44.42.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. The company had revenue of $235.60 million during the quarter, compared to analyst estimates of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm's revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.3%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio is 165.43%.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.